Business Description
Nirvana Life Sciences Inc
NAICS : 541713
SIC : 3741
ISIN : CA6546521064
Description
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | -3.83 | |||||
| Debt-to-Equity | -0.03 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -60.1 | |||||
| 3-Year EPS without NRI Growth Rate | -48.9 | |||||
| 3-Year FCF Growth Rate | -115.4 | |||||
| 3-Year Book Growth Rate | -20.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.41 | |||||
| 9-Day RSI | 47.4 | |||||
| 14-Day RSI | 42.1 | |||||
| 6-1 Month Momentum % | 650 | |||||
| 12-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.05 | |||||
| Quick Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1 | |||||
| Shareholder Yield % | -6.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -741.55 | |||||
| ROIC % | -792.72 | |||||
| 3-Year ROIIC % | 441.73 | |||||
| ROC (Joel Greenblatt) % | -429.07 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.98 | |||||
| EV-to-EBITDA | -2.04 | |||||
| EV-to-FCF | -9.63 | |||||
| Earnings Yield (Greenblatt) % | -50.51 | |||||
| FCF Yield % | -10.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nirvana Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.033 | ||
| Beta | 0 | ||
| Volatility % | 325.65 | ||
| 14-Day RSI | 42.1 | ||
| 14-Day ATR (C$) | 0.002203 | ||
| 20-Day SMA (C$) | 0.04875 | ||
| 12-1 Month Momentum % | 200 | ||
| 52-Week Range (C$) | 0.01 - 0.08 | ||
| Shares Outstanding (Mil) | 48.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nirvana Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nirvana Life Sciences Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nirvana Life Sciences Inc Frequently Asked Questions
What is Nirvana Life Sciences Inc(XCNQ:NIRV)'s stock price today?
The current price of XCNQ:NIRV is C$0.05. The 52 week high of XCNQ:NIRV is C$0.08 and 52 week low is C$0.01.
When is next earnings date of Nirvana Life Sciences Inc(XCNQ:NIRV)?
The next earnings date of Nirvana Life Sciences Inc(XCNQ:NIRV) is .
Does Nirvana Life Sciences Inc(XCNQ:NIRV) pay dividends? If so, how much?
Nirvana Life Sciences Inc(XCNQ:NIRV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers